ActiTest Score Test

Your liver can be quietly inflamed for years before anything shows up on a basic blood panel or a scan. That inflammation, the kind that slowly scars and scars until function is gone, is exactly what this score tries to measure. If you have fatty liver, a history of hepatitis, heavy alcohol exposure, or you are just trying to understand whether your liver is handling your metabolic load, knowing whether the organ is calm or actively injured is a different piece of information than knowing you have fat in it.

ActiTest is a calculated score, not a single molecule. It combines six routine blood results (ALT, gamma-glutamyltransferase, bilirubin, haptoglobin, alpha-2-macroglobulin, and apolipoprotein A1) with your age and sex into a number between 0 and 1. Higher numbers suggest more active injury and inflammation inside the liver tissue.

What the Score Actually Reflects

A standard liver panel tells you whether your liver enzymes are elevated. It does not tell you, in any structured way, whether the liver is going through a phase of active inflammation and cell death (what pathologists call necro-inflammatory activity). ActiTest was built specifically to grade that activity on a scale similar to what a pathologist would assign after looking at a biopsy slide.

The score maps onto four grades used by liver pathologists, from A0 (little to no active injury) through A3 (severe active injury). It was originally validated in chronic hepatitis C, then extended to hepatitis B, fatty liver disease tied to obesity and diabetes, and alcohol-related liver disease.

Chronic Hepatitis C

In chronic hepatitis C, ActiTest is one of the main non-invasive tools for deciding whether liver inflammation is moderate or severe. For detecting moderate-to-severe activity (grades A2 to A3) compared against biopsy, the test achieves an area under the curve of about 0.73. When the ActiTest and its sister test FibroTest disagree with a biopsy result, the disagreement is more often a biopsy failure than a score failure, which matters because biopsy has long been treated as the benchmark.

Chronic Hepatitis B

In hepatitis B, ActiTest performs at an area under the curve of 0.81 to 0.82 for detecting active inflammation, comparable to simply looking at your AST and ALT. More usefully, combining an ActiTest score in the lowest category with a low FibroTest score and a low viral load identified hepatitis B carriers who were genuinely inactive, with a 100% negative predictive value for liver-related complications or death over 4 years of follow-up in a cohort of 1,074 people. This is the kind of test-pattern interpretation where ActiTest earns its keep.

Fatty Liver Disease and Severe Obesity

In people with severe obesity undergoing evaluation for bariatric surgery, ActiTest detected steatohepatitis (the inflamed form of fatty liver, where a non-alcoholic steatohepatitis activity score is above 4) with an area under the curve between 0.74 and 0.84. That beats relying on ALT alone, which is what most primary care visits stop at. In a separate study of 600 people with biopsy-proven fatty liver disease, ActiTest correlated well with the activity piece of the pathologist's grading system.

Alcohol-Related Liver Disease

In 265 people with compensated alcohol-associated liver disease, at an ActiTest cutoff of 0.18, the score correctly identified 84 out of 100 cases of severe inflammation but produced a lot of false positives, with only 60% specificity. A newer marker called keratin-18 (M30) and simple AST outperformed ActiTest for both detection and predicting future liver events in this population. If alcohol is your concern, ActiTest is useful but not the sharpest tool available.

Reference Ranges

These ranges come from the developer's validation studies in chronic hepatitis populations and from bariatric cohorts, using the proprietary FibroMax algorithm. They are orientation, not a target. Your lab may report slightly different cutpoints. Compare your result to your own previous readings, ideally from the same lab, rather than treating a single number as final.

What this means for you: if your score lands in A2 or A3 territory, the liver is in an active phase of injury, and the cause needs to be identified and treated, whether that is a viral infection, metabolic dysfunction, alcohol, or a drug exposure. A score in A0 is reassuring but does not rule out fibrosis (scarring), which is measured separately by FibroTest.

Tracking Your Trend

A single ActiTest score is a snapshot. Liver activity waxes and wanes with viral load, alcohol intake, weight, medications, and metabolic control. One number gives you a category, but the direction the number is moving over months tells you whether the underlying process is calming down or accelerating.

Serial tracking is where this test shines. In a study of 288 people with chronic hepatitis B treated with antiviral therapy, the mean ActiTest score fell from 0.56 at baseline to 0.13 over 24 months, tracking the clinical improvement their liver was undergoing. That kind of trajectory is invisible from one reading. Get a baseline, retest in 3 to 6 months if you are making meaningful changes (treatment, weight loss, abstinence from alcohol), and at least annually if you are stable. If your score is rising, that is a signal to look closer long before liver scarring sets in.

What to Do With an Abnormal Result

A single elevated ActiTest should not be acted on in isolation. It is almost always ordered as part of the FibroMax panel, which also reports FibroTest (fibrosis or scarring), SteatoTest (fat in the liver), and NashTest (probability of steatohepatitis). The pattern across these four scores is what matters. High activity with low fibrosis suggests inflammation that has not yet scarred the organ, which is often reversible. High activity with high fibrosis is more urgent.

If your score suggests moderate-to-severe activity, the next steps typically include a viral hepatitis workup (if not already done), a careful review of alcohol intake and medications, imaging such as a FibroScan or liver ultrasound, and a referral to a hepatologist if the activity and fibrosis pattern is concerning. Do not wait for symptoms. By the time a damaged liver produces symptoms, the window for reversal has narrowed.

When Results Can Be Misleading

Because ActiTest is built from six component tests, anything that distorts one of the inputs can shift the score without reflecting a real change in liver inflammation. Common distorters to be aware of:

• Acute illness or recent inflammation: infections, surgery, or systemic inflammatory events can shift haptoglobin and alpha-2-macroglobulin in ways that change the score without reflecting liver biology. Wait until you have fully recovered before testing.
• Hemolysis in the blood sample: breakdown of red blood cells during a draw lowers haptoglobin artificially. A botched blood draw can alter the result.
• Gilbert's syndrome: a common benign genetic condition that raises bilirubin without liver injury can push the score upward without any underlying disease.
• High discordance rate with biopsy: in chronic hepatitis C, roughly 17% of results disagree with a biopsy finding. When they disagree, it is more often the biopsy at fault, but this means a single reading should not override the rest of your clinical picture.

How This Fits Alongside a Standard Liver Panel

A routine metabolic panel tells you whether your ALT and AST are elevated. That is a trip-wire for liver trouble, not a grading system. ActiTest takes those same enzymes and adds the protein chemistry that reflects how the liver is responding (or failing to respond) to ongoing injury, then combines everything into a score that mirrors what a pathologist would assign. It answers a different question: not whether the liver is leaking enzymes, but how actively damaged it is right now.